{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pathophysiology and Treatment of Malignant Hyperthermia

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify a triggering agent for MH.
  2. Explain treatment considerations for a patient with MH.
  3. Recognize potential complications of MH and dantrolene administration.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: AENJ0421A
Published: Apr/Jun 2021
Expires: 6/2/2023
Required Passing Score: 7/10 (70%)
Authors: Haili Gregory, PharmD, BCPS; Kyle A. Weant, PharmD, BCPS, BCCCP, FCCP